Aug 2, 2020
Patients Rising Now Comments on ICER Draft Evidence Report: “Targeted Immune Modulators for Ulcerative Colitis: Effectiveness and...
Nov 9, 2019
Patients Rising Now appreciates the opportunity to provide our comments on ICER’s October 11th Draft Evidence Report “Janus Kinase Inhibitors for Rheumatoid Arthritis.” We are also encouraged that ICER delayed the release of the draft report to revise and update its...
Oct 19, 2019
Patients Rising Now is welcomes the opportunity to provide recommendations and comments about the pros and cons of ICER’s August 21st document outlining proposed changes to its Value Assessment Framework’s processes and methodology. As advocates for patients with...
Oct 19, 2019
Institute for Patient Access & Affordability (IPAA) is a new program division of Patients Rising with the mission to provide patient-powered pathways to help both public and private payers as they make critical coverage decisions for patients with rare and chronic...
